Regional variation of the off-licence use of rFVIIa for patients with uncontrolled haemorrhage in England

समान संसाधन

• Analysis of the off-licence use of recombinant activated factor VII for patients with uncontrolled haemorrhage in a UK tertiary referral hospital
  द्वारा: Spivey, M, और अन्य
  प्रकाशित: (2009)
• Analysis of red cell transfusion practices in patients without active haemorrhage over a 12-month period in a UK intensive care unit
  द्वारा: Eve, RL, और अन्य
  प्रकाशित: (2010)
• Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven(®)) in obstetrical haemorrhagic shock
  द्वारा: Sobieszczyk, S, और अन्य
  प्रकाशित: (2003)
• Nebulised recombinant activated factor VII (rFVIIa) does not attenuate the haemorrhagic effects of blast lung injury
  द्वारा: Smith, Jason E, और अन्य
  प्रकाशित: (2019)
• Bioengineering of rFVIIa Biopharmaceutical and Structure Characterization for Biosimilarity Assessment
  द्वारा: Montacir, Othman, और अन्य
  प्रकाशित: (2018)